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What is current knowledge: 
• Prevalence of recreational ketamine use is increasing. 
 
What is new here: 
• Ketamine-induced cholangiopathy with important differential diagnoses excluded.
To the Editor: 
 A 32-year-old lady was referred to our care in April 2006 with on and off 
epigastric discomfort. She had been inhaling ketamine for recreational use for seven 
years, and also had lower urinary tract symptoms related to long-term ketamine use. 
Her liver function was deranged with an elevation of her serum alkaline phosphatase 
(ALP) and gamma-glutamyl tansferase (GGT) to 229U/L and 284U/L respectively; her 
bilirubin level and parenchymal liver enzymes were relatively normal. Endoscopic 
retrograde cholangiopancreatography (ERCP) showed multiple long-segment strictures 
and narrowing in the intrahepatic ducts of both lobes (Figure 1). The common bile duct 
was also mildly dilated with no filling defects. The pancreatic duct was normal. ERCP 
had been repeated nine times over the past 4 years with similar results; brush cytology 
of dominant strictures obtained each time revealed only reactive changes.  
 Additional investigations to exclude other causes of biliary disease had been 
performed. She was negative for anti-mitochondrial antibody (AMA), anti-nuclear 
antibody (ANA) and anti-HIV antibody. Her serum CA 19.9 and Immunoglobulin G4 
(IgG4) levels were normal. A liver biopsy with 12 portal tracts obtained in 2008 showed 
mild non-specific inflammation of the portal tracts, with no portal or periductal fibrosis 
(Figure 2). There was no ductopenia to suggest primary biliary cirrhosis (PBC) and no 
significant portal fibrosis or heavy inflammatory infiltrates to suggest recurrent pyogenic 
cholangitis (RPC). The classical periductal “onion-skin” fibrosis suggestive of primary 
sclerosing cholangitis (PSC) was not seen. Colonoscopy with biopsies failed to show 
any evidence of co-existing inflammatory bowel disease (IBD). 
   Ketamine is an N-methyl-D-aspartate (NMDA) antagonist that was first used in 
clinical practice in the 1970s as an anaesthetic. Its hallucinogenic side-effects and easy 
administration by inhalation has made it an increasingly common recreational drug. At 
low doses, it can result in euphoria and mild sensory and perceptual distortion. Higher 
doses can result in out-of-body and floating experiences. Its recreational use is 
extremely common in Asia, especially in Taiwan and Hong Kong. Its prevalence is also 
on the rise in the United Kingdom (1), especially in the adolescent population.  
 While long-term ketamine inhalation has been known to be associated with 
bladder dysfunction (2), its effects on the biliary system have been less well-defined. An 
animal study has shown ketamine can increase the flow resistance across the sphincter 
of Oddi (3). There has been only one report of 3 cases with biliary tract abnormalities 
associated with ketamine use (4), although important differential diagnosis have not 
been thoroughly excluded in these patients. 
 We postulate our patient’s biliary abnormalities are the result of long-term 
ketamine usage. Important differential diagnoses for this patient include PBC, PSC, 
RPC, IgG4-positive sclerosing cholangitis, and AIDS-cholangiopathy. PBC is excluded 
based on a negative serum AMA and her abnormal cholangiograms. PSC is still a 
possible diagnosis, although it is a rare disease in Asia and its prevalence outside of 
Indian and Japan is unknown (5). Moreover, intrahepatic strictures in PSC are usually 
short and annular in a “beaded” pattern instead of the long strictures present in this 
patient. There were also no histological features of PSC in her liver biopsy, and co-
existing IBD has been excluded. While RPC is a common disease in southeast Asia, the 
lack of intrahepatic filling defects on multiple cholangiograms and the non-specific 
biopsy findings do not support this diagnosis. A normal serum IgG4 and a negative HIV 
status have excluded the remaining two differential diagnoses. 
 In conclusion, long-term ketamine usage can lead to gross biliary abnormalities 
resulting in recurrent epigastric discomfort and raised ductal enzymes. Clinicians should 
be aware of this association especially in countries where the recreational use of 
ketamine is rising.  
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